Skip to content Provide accessibility feedback
By using the Volpara website you accept our use of cookies. Here’s our privacy statement.
Breast Health
For Patients
Contact us
Magnifying glass Search

Breast cancer risk assessment and its role in optimizing screening and treatment strategies

Volpara Health – Published on October 21, 2021

Interview with Ralph Highnam, Founder and CEO of Volpara Health
DI Europe, October 2021

Renowned throughout the world for its breast density assessment software and breast imaging QC systems, Volpara Health Technologies has announced that it has recently acquired the US-based company CRA Health which develops breast cancer risk assessment software.

We wanted to find out more about the rationale behind the acquisition and the current status and future potential of breast cancer risk assessment in general, so we spoke to Dr. Ralph Highnam, CEO of Volpara.

Read the full article.